{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:42:49Z","timestamp":1793162569380,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"International Cooperation Research Center for the Prevention and Treatment of Diabetes by Traditional Chinese Medicine","award":["2015B01022"],"award-info":[{"award-number":["2015B01022"]}]},{"name":"Traditional Chinese Medicine intervention of metabolic diseases research project","award":["90020165120003"],"award-info":[{"award-number":["90020165120003"]}]},{"name":"Key Laboratory Health Cultivation of the Ministry of Education Preservation","award":["2024-JYB-KYPT-002"],"award-info":[{"award-number":["2024-JYB-KYPT-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06302-y","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:45:52Z","timestamp":1743745552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Glucagon-like Peptide-1 receptor agonists for obstructive sleep apnea in patients with obesity and type 2 diabetes mellitus: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Ruifeng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"6302_CR1","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1001\/jama.2020.3514","volume":"323","author":"DJ Gottlieb","year":"2020","unstructured":"Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: A review. JAMA. 2020;323:1389\u2013400.","journal-title":"JAMA"},{"key":"6302_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0140-6736(13)60734-5","volume":"383","author":"AS Jordan","year":"2014","unstructured":"Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep Apnoea. Lancet. 2014;383:736\u201347.","journal-title":"Lancet"},{"key":"6302_CR3","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1056\/NEJMcp1816152","volume":"380","author":"SC Veasey","year":"2019","unstructured":"Veasey SC, Rosen IM. Obstructive sleep apnea in adults. N Engl J Med. 2019;380:1442\u20139.","journal-title":"N Engl J Med"},{"key":"6302_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","volume":"7","author":"AV Benjafield","year":"2019","unstructured":"Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, P\u00e9pin JLD, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. LANCET RESPIRATORY Med. 2019;7:687\u201398.","journal-title":"LANCET RESPIRATORY Med"},{"key":"6302_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1183\/13993003.01148-2015","volume":"47","author":"ES Arnardottir","year":"2016","unstructured":"Arnardottir ES, Bjornsdottir E, Olafsdottir KA, Benediktsdottir B, Gislason T. Obstructive sleep Apnoea in the general population: highly prevalent but minimal symptoms. Eur Respir J. 2016;47:194\u2013202.","journal-title":"Eur Respir J"},{"key":"6302_CR6","doi-asserted-by":"publisher","first-page":"e12770","DOI":"10.1111\/jsr.12770","volume":"28","author":"I Fietze","year":"2019","unstructured":"Fietze I, Laharnar N, Obst A, Ewert R, Felix SB, Garcia C, Glaser S, Glos M, Schmidt CO, Stubbe B, et al. Prevalence and association analysis of obstructive sleep apnea with gender and age differences - Results of SHIP-Trend. J Sleep Res. 2019;28:e12770.","journal-title":"J Sleep Res"},{"key":"6302_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S2213-2600(15)00043-0","volume":"3","author":"R Heinzer","year":"2015","unstructured":"Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, et al. Prevalence of sleep-disordered breathing in the general population: the hypnolaus study. Lancet Respir Med. 2015;3:310\u20138.","journal-title":"Lancet Respir Med"},{"key":"6302_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.201312-2209OC","volume":"190","author":"T Kendzerska","year":"2014","unstructured":"Kendzerska T, Gershon AS, Hawker G, Tomlinson G, Leung RS. Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respir Crit Care Med. 2014;190:218\u201325.","journal-title":"Am J Respir Crit Care Med"},{"key":"6302_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.sleep.2009.10.005","volume":"11","author":"S Tufik","year":"2010","unstructured":"Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo epidemiologic sleep study. Sleep Med. 2010;11:441\u20136.","journal-title":"Sleep Med"},{"key":"6302_CR10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2337\/dc08-1776","volume":"32","author":"GD Foster","year":"2009","unstructured":"Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, Wadden TA, Kelley D, Wing RR, Sunyer FX, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32:1017\u20139.","journal-title":"Diabetes Care"},{"key":"6302_CR11","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1007\/s11695-015-1953-7","volume":"26","author":"P Peromaa-Haavisto","year":"2016","unstructured":"Peromaa-Haavisto P, Tuomilehto H, Kossi J, Virtanen J, Luostarinen M, Pihlajamaki J, Kakela P, Victorzon M. Prevalence of obstructive sleep Apnoea among patients admitted for bariatric surgery. A prospective multicentre trial. Obes Surg. 2016;26:1384\u201390.","journal-title":"Obes Surg"},{"key":"6302_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11695-009-9928-1","volume":"21","author":"AE Sareli","year":"2011","unstructured":"Sareli AE, Cantor CR, Williams NN, Korus G, Raper SE, Pien G, Hurley S, Maislin G, Schwab RJ. Obstructive sleep apnea in patients undergoing bariatric surgery\u2013a tertiary center experience. Obes Surg. 2011;21:316\u201327.","journal-title":"Obes Surg"},{"key":"6302_CR13","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/aje\/kws342","volume":"177","author":"PE Peppard","year":"2013","unstructured":"Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006\u201314.","journal-title":"Am J Epidemiol"},{"key":"6302_CR14","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1001\/jama.284.23.3015","volume":"284","author":"PE Peppard","year":"2000","unstructured":"Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284:3015\u201321.","journal-title":"JAMA"},{"key":"6302_CR15","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1164\/rccm.200504-637OC","volume":"172","author":"KJ Reichmuth","year":"2005","unstructured":"Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med. 2005;172:1590\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"6302_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S2213-2600(13)70039-0","volume":"1","author":"RN Aurora","year":"2013","unstructured":"Aurora RN, Punjabi NM. Obstructive sleep Apnoea and type 2 diabetes mellitus: a bidirectional association. Lancet Respir Med. 2013;1:329\u201338.","journal-title":"Lancet Respir Med"},{"key":"6302_CR17","first-page":"1322","volume":"55","author":"R Budhiraja","year":"2010","unstructured":"Budhiraja R, Budhiraja P, Quan SF. Sleep-disordered breathing and cardiovascular disorders. Respir Care. 2010;55:1322\u201332. discussion 1330\u2013\u20091322.","journal-title":"Respir Care"},{"key":"6302_CR18","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC201912030","volume":"171","author":"SR Patel","year":"2019","unstructured":"Patel SR. Obstructive sleep apnea. Ann Intern Med. 2019;171:ITC81\u201396.","journal-title":"Ann Intern Med"},{"key":"6302_CR19","doi-asserted-by":"publisher","first-page":"101809","DOI":"10.1016\/j.smrv.2023.101809","volume":"70","author":"YC Lee","year":"2023","unstructured":"Lee YC, Lu CT, Chuang LP, Lee LA, Fang TJ, Cheng WN, Li HY. Pharmacotherapy for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2023;70:101809.","journal-title":"Sleep Med Rev"},{"key":"6302_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/thx.56.7.513","volume":"56","author":"N McArdle","year":"2001","unstructured":"McArdle N, Kingshott R, Engleman HM, Mackay TW, Douglas NJ. Partners of patients with sleep Apnoea\/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life. Thorax. 2001;56:513\u20138.","journal-title":"Thorax"},{"key":"6302_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5664\/jcsm.7640","volume":"15","author":"SP Patil","year":"2019","unstructured":"Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2019;15:335\u201343.","journal-title":"J Clin Sleep Med"},{"key":"6302_CR22","first-page":"CD010990","volume":"5","author":"PR Srijithesh","year":"2019","unstructured":"Srijithesh PR, Aghoram R, Goel A, Dhanya J. Positional therapy for obstructive sleep Apnoea. Cochrane Database Syst Rev. 2019;5:CD010990.","journal-title":"Cochrane Database Syst Rev"},{"key":"6302_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.smrv.2004.01.002","volume":"8","author":"V Wittmann","year":"2004","unstructured":"Wittmann V, Rodenstein DO. Health care costs and the sleep apnea syndrome. Sleep Med Rev. 2004;8:269\u201379.","journal-title":"Sleep Med Rev"},{"key":"6302_CR24","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1513\/AnnalsATS.202101-060OC","volume":"18","author":"B Chen","year":"2021","unstructured":"Chen B, Drager LF, Peker Y, Vgontzas AN, Phillips CL, Hoyos CM, Salles GF, Guo M, Li Y. Effect of continuous positive airway pressure on weight and local adiposity in adults with obstructive sleep apnea: A Meta-Analysis. Ann Am Thorac Soc. 2021;18:1717\u201327.","journal-title":"Ann Am Thorac Soc"},{"key":"6302_CR25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJMc1611289","volume":"375","author":"S Cohen","year":"2016","unstructured":"Cohen S, Beckey C. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:1797.","journal-title":"N Engl J Med"},{"key":"6302_CR26","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del PS, Mathieu C, Mingrone G, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care. 2022;45:2753\u201386.","journal-title":"Diabetes Care"},{"key":"6302_CR27","first-page":"e4","volume":"385","author":"E Javor","year":"2021","unstructured":"Javor E, Lucijanic M, Skelin M. Once-Weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;385:e4.","journal-title":"N Engl J Med"},{"key":"6302_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S2213-8587(19)30311-0","volume":"7","author":"I Lingvay","year":"2019","unstructured":"Lingvay I, Catarig AM, Frias JP, Kumar H, Lausvig NL, le Roux CW, Thielke D, Viljoen A, McCrimmon RJ. Efficacy and safety of once-weekly semaglutide versus daily Canagliflozin as add-on to Metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7:834\u201344.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6302_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante OR, Jensen CB, Wilding JP. A randomized, controlled trial of 3.0\u00a0mg of liraglutide in weight management. N Engl J Med. 2015;373:11\u201322.","journal-title":"N Engl J Med"},{"key":"6302_CR30","first-page":"224","volume":"12","author":"S Dragonieri","year":"2024","unstructured":"Dragonieri S, Portacci A, Quaranta VN, Carratu P, Lazar Z, Carpagnano GE, Bikov A. Therapeutic potential of Glucagon-like Peptide-1 receptor agonists in obstructive sleep apnea syndrome management: A narrative review. Dis (Basel Switzerland). 2024;12:224.","journal-title":"Dis (Basel Switzerland)"},{"key":"6302_CR31","first-page":"281","volume":"47","author":"BN Zhou","year":"2024","unstructured":"Zhou BN, Liu X, Hu K. Research status of glucagon-like peptide-1 receptor agonists on obstru Ctive sleep apnea. Zhonghua Jie he he Hu Xi Za zhi\u2009=\u2009zhonghua Jiehe he Huxi Zazhi\u2009=\u2009Chine. Se J Tuberculosis Respiratory Dis. 2024;47:281\u20135.","journal-title":"Se J Tuberculosis Respiratory Dis"},{"key":"6302_CR32","doi-asserted-by":"crossref","unstructured":"Li M, Lin H, Yang Q, Zhang X, Zhou Q, Shi J, Ge F. Glucagon-like peptide 1 receptor agonists for the treatment of obstruc Tive sleep apnea: a meta-analysis. Sleep 2024:zsae280.","DOI":"10.1093\/sleep\/zsae280"},{"key":"6302_CR33","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Res ed). 2021;372:n71.","journal-title":"BMJ (Clinical Res ed)"},{"key":"6302_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5664\/jcsm.6506","volume":"13","author":"VK Kapur","year":"2017","unstructured":"Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2017;13:479\u2013504.","journal-title":"J Clin Sleep Med"},{"key":"6302_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"6302_CR36","first-page":"l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Res ed). 2019;366:l4898.","journal-title":"BMJ (Clinical Res ed)"},{"key":"6302_CR37","doi-asserted-by":"crossref","unstructured":"Lortie CJ. Doing Meta-Analysis with R - A Hands-On guide. J Stat Softw 2022, 102.","DOI":"10.18637\/jss.v102.b02"},{"key":"6302_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"6302_CR39","doi-asserted-by":"crossref","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to meta-analysis. Wiley; 2021.","DOI":"10.1002\/9781119558378"},{"key":"6302_CR40","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2016","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2016;27:1785\u2013805.","journal-title":"Stat Methods Med Res"},{"key":"6302_CR41","doi-asserted-by":"publisher","first-page":"d2304","DOI":"10.1136\/bmj.d2304","volume":"343","author":"DG Altman","year":"2011","unstructured":"Altman DG, Bland JM. How to obtain the P value from a confidence interval. BMJ. 2011;343:d2304.","journal-title":"BMJ"},{"key":"6302_CR42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<753::AID-SIM494>3.0.CO;2-G","volume":"16","author":"B Biggerstaff","year":"1997","unstructured":"Biggerstaff B, Tweedie R. Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Stat Med. 1997;16:753\u201368.","journal-title":"Stat Med"},{"key":"6302_CR43","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, Gluud C. Trial sequential analysis (TSA). Copenhagen Trial Unit; 2017."},{"key":"6302_CR44","unstructured":"NCT01136798. Impact of exenatide on sleep in type 2 diabetes. https:\/\/clinicaltrialsgov\/study\/NCT01136798 2010."},{"key":"6302_CR45","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s11325-022-02768-y","volume":"27","author":"W Jiang","year":"2023","unstructured":"Jiang W, Li W, Cheng J, Li W, Cheng F. Efficacy and safety of liraglutide in patients with type 2 diabetes mellitus and severe obstructive sleep apnea. SLEEP Breath. 2023;27:1687\u201394.","journal-title":"SLEEP Breath"},{"key":"6302_CR46","unstructured":"EU Clinical Trials Register. Continuous positive airway pressure with or without liraglutide in obstructive sleep apnoea and type 2 diabetes (ROMANCE). https:\/\/trialsearchwhoint\/Trial2aspx?TrialID=EUCTR2014-000988-41-GB 2014."},{"key":"6302_CR47","doi-asserted-by":"publisher","first-page":"A264","DOI":"10.1093\/sleep\/zsae067.0620","volume":"47","author":"RR Grunstein","year":"2024","unstructured":"Grunstein RR, Taylor R, Shinde S, Dunn JP, Bednarik J, Stefanski A, Falcon B. Effect of tirzepatide on weight loss in patients with obstructive sleep apnea and obesity from surmount-1. Sleep. 2024;47:A264\u20135.","journal-title":"Sleep"},{"key":"6302_CR48","doi-asserted-by":"crossref","unstructured":"Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, Sands SA, Schwab RJ, Dunn JP, Chakladar S. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med 2024.","DOI":"10.1056\/NEJMoa2404881"},{"key":"6302_CR49","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ijo.2016.52","volume":"40","author":"A Blackman","year":"2016","unstructured":"Blackman A, Foster GD, Zammit G, Rosenberg R, Aronne L, Wadden T, Claudius B, Jensen CB, Mignot E. Effect of liraglutide 3.0\u00a0mg in individuals with obesity and moderate or severe obstructive sleep apnea: the scale sleep apnea randomized clinical trial. Int J Obes. 2016;40:1310\u20139.","journal-title":"Int J Obes"},{"key":"6302_CR50","doi-asserted-by":"crossref","unstructured":"Dogan ADA, Hess S, Jensen TT, Bladbjerg E-M, Juhl CB, Hilberg O. Effects of Treatment with Liraglutide on Health Related Quality of Life and Obstructive Sleep Apnea in People with Obesity and Chronic Obstructive Pulmonary Disease. Preprint 2022.","DOI":"10.21203\/rs.3.rs-1665063\/v1"},{"key":"6302_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1513\/AnnalsATS.202309-821OC","volume":"21","author":"C O\u2019Donnell","year":"2024","unstructured":"O\u2019Donnell C, Crilly S, O\u2019Mahony A, O\u2019Riordan B, Traynor M, Gitau R, McDonald K, Ledwidge M, O\u2019Shea D, Murphy DJ, et al. Continuous positive airway pressure but not GLP1-mediated weight loss improves early cardiovascular disease in obstructive sleep apnea: A randomized Proof-of-Concept study. Ann Am Thorac Soc. 2024;21:464\u201373.","journal-title":"Ann Am Thorac Soc"},{"key":"6302_CR52","unstructured":"Amin RS, Simakajornboon N, Szczesniak RV. Treatment Of Obstructive Sleep Apnea With Glucagon Like Peptide-1 Receptor Agonist. American Journal of Respiratory and Critical Care Medicine 2015, 191:A4144."},{"key":"6302_CR53","first-page":"86","volume":"12","author":"K Liu","year":"2020","unstructured":"Liu K, Yuan H, Wang D, Yuan Q, Shi X. Effects of liraglutide on sleep-disordered breathing and diabetic microangiopathy in patients with type 2 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome. Chin J Diabetes Mellitus. 2020;12:86\u201391.","journal-title":"Chin J Diabetes Mellitus"},{"key":"6302_CR54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11121-013-0377-7","volume":"14","author":"M Borenstein","year":"2013","unstructured":"Borenstein M, Higgins JP. Meta-analysis and subgroups. Prev Sci. 2013;14:134\u201343.","journal-title":"Prev Sci"},{"key":"6302_CR55","doi-asserted-by":"crossref","unstructured":"Grote L, Anderberg CP, Friberg D, Grundstr\u00f6m G, Hinz K, Isaksson G, Murto T, Nilsson Z, Spaak J, Stillberg G et al. National Knowledge-Driven management of obstructive sleep Apnea-The Swedish approach. Diagnostics (Basel) 2023, 13.","DOI":"10.3390\/diagnostics13061179"},{"key":"6302_CR56","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/eurheartj\/ehy624","volume":"40","author":"A Azarbarzin","year":"2019","unstructured":"Azarbarzin A, Sands SA, Stone KL, Taranto-Montemurro L, Messineo L, Terrill PI, Ancoli-Israel S, Ensrud K, Purcell S, White DP, et al. The hypoxic burden of sleep Apnoea predicts cardiovascular disease-rel Ated mortality: the osteoporotic fractures in men study and the sleep heart health study. Eur Heart J. 2019;40:1149\u201357.","journal-title":"Eur Heart J"},{"key":"6302_CR57","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s11325-019-01967-4","volume":"24","author":"G Labarca","year":"2020","unstructured":"Labarca G, Gower J, Lamperti L, Dreyse J, Jorquera J. Chronic intermittent hypoxia in obstructive sleep apnea: a narrative R Eview from pathophysiological pathways to a precision clinical approach. Sleep Breath = Schlaf Atmung. 2020;24:751\u201360.","journal-title":"Sleep Breath = Schlaf Atmung"},{"key":"6302_CR58","doi-asserted-by":"crossref","unstructured":"Gomez-Peralta F, Abreu C, Castro JC, Alcarria E, Cruz-Bravo M, Garcia-Llorente MJ, Albornos C, Moreno C, Cepeda M, Almod\u00f3var F. An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes. BMC Endocr Disorders 2015, 15.","DOI":"10.1186\/s12902-015-0074-6"},{"key":"6302_CR59","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1365-2869.2012.01030.x","volume":"22","author":"I Idris","year":"2013","unstructured":"Idris I, Abdulla H, Tilbrook S, Dean R, Ali N. Exenatide improves excessive daytime sleepiness and wakefulness in obese patients with type 2 diabetes without obstructive sleep Apnoea. J Sleep Res. 2013;22:70\u20135.","journal-title":"J Sleep Res"},{"key":"6302_CR60","doi-asserted-by":"crossref","unstructured":"Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R, Reviewers of the AACEOCPG: American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medic. Endocr Practice: Official J Am Coll Endoc Rinology Am Association Clin Endocrinologists, 22 Suppl 3:1\u2013203.","DOI":"10.4158\/EP161365.GL"},{"key":"6302_CR61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.acvd.2020.01.003","volume":"113","author":"C Arnaud","year":"2020","unstructured":"Arnaud C, Bochaton T, Pepin JL, Belaidi E. Obstructive sleep Apnoea and cardiovascular consequences: pathophysiological mechanisms. Arch Cardiovasc Dis. 2020;113:350\u20138.","journal-title":"Arch Cardiovasc Dis"},{"key":"6302_CR62","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000988","volume":"144","author":"Y Yeghiazarians","year":"2021","unstructured":"Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, Mehra R, Bozkurt B, Ndumele CE, Somers VK. Obstructive sleep apnea and cardiovascular disease: A scientific statement from the American heart association. Circulation. 2021;144:e56\u201367.","journal-title":"Circulation"},{"key":"6302_CR63","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.5114\/amsad\/161170","volume":"8","author":"GS Papaetis","year":"2023","unstructured":"Papaetis GS. GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy? Arch Med Sci Atheroscler Dis. 2023;8:e19\u201334.","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"6302_CR64","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2337\/dc18-0675","volume":"41","author":"T Huang","year":"2018","unstructured":"Huang T, Lin BM, Stampfer MJ, Tworoger SS, Hu FB, Redline S. A Population-Based study of the bidirectional association between obstructive sleep apnea and type 2 diabetes in three prospective U.S. Cohorts. Diabetes Care. 2018;41:2111\u20139.","journal-title":"Diabetes Care"},{"key":"6302_CR65","doi-asserted-by":"publisher","first-page":"101663","DOI":"10.1016\/j.smrv.2022.101663","volume":"65","author":"S Ai","year":"2022","unstructured":"Ai S, Li Z, Wang S, Chen S, Chan JW, Au CT, Bao Y, Li AM, Zhang J, Chan KC-C, Wing Y-K. Blood pressure and childhood obstructive sleep apnea: A systematic rev Iew and meta-analysis. Sleep Med Rev. 2022;65:101663.","journal-title":"Sleep Med Rev"},{"key":"6302_CR66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11886-020-1257-y","volume":"22","author":"LA Salman","year":"2020","unstructured":"Salman LA, Shulman R, Cohen JB. Obstructive sleep apnea, hypertension, and cardiovascular risk: epidem iology, pathophysiology, and management. Curr Cardiol Rep. 2020;22:6.","journal-title":"Curr Cardiol Rep"},{"key":"6302_CR67","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1172\/JCI97233","volume":"127","author":"DJ Drucker","year":"2017","unstructured":"Drucker DJ, Habener JF, Holst JJ. Discovery, characterization, and clinical development of the glucagon-like peptides. J Clin Invest. 2017;127:4217\u201327.","journal-title":"J Clin Invest"},{"key":"6302_CR68","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87:1409\u201339.","journal-title":"Physiol Rev"},{"key":"6302_CR69","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","volume":"17","author":"JE Campbell","year":"2013","unstructured":"Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013;17:819\u201337.","journal-title":"Cell Metab"},{"key":"6302_CR70","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.1002\/edm2.462","volume":"7","author":"Z Mariam","year":"2024","unstructured":"Mariam Z, Niazi SK. Glucagon-like peptide agonists: A prospective review. Endocrinol Diabetes Metab. 2024;7:e462.","journal-title":"Endocrinol Diabetes Metab"},{"key":"6302_CR71","doi-asserted-by":"publisher","first-page":"817","DOI":"10.4239\/wjd.v5.i6.817","volume":"5","author":"GS Papaetis","year":"2014","unstructured":"Papaetis GS. Incretin-based therapies in prediabetes: current evidence and future perspectives. World J Diabetes. 2014;5:817\u201334.","journal-title":"World J Diabetes"},{"key":"6302_CR72","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/MOG.0000000000000308","volume":"32","author":"ML Schubert","year":"2016","unstructured":"Schubert ML. Gastric acid secretion. Curr Opin Gastroenterol. 2016;32:452\u201360.","journal-title":"Curr Opin Gastroenterol"},{"key":"6302_CR73","unstructured":"Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstr\u00f6m PM. Inhibitory effect of Glucagon-like Peptide-1 on small bowel motility. The American Society for Clinical Investigation; 1998."},{"key":"6302_CR74","doi-asserted-by":"crossref","unstructured":"Schirra J, Houck P, Wank U, Arnold R, G\u00f6ke B, Katschinski M. Effects of glucagon-like peptide-1(7\u201336)amide on antro-pyloro- duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans. Gut 2000.","DOI":"10.1136\/gut.46.5.622"},{"key":"6302_CR75","doi-asserted-by":"publisher","first-page":"1085799","DOI":"10.3389\/fendo.2023.1085799","volume":"14","author":"JY Wang","year":"2023","unstructured":"Wang JY, Wang QW, Yang XY, Yang W, Li DR, Jin JY, Zhang HC, Zhang XF. GLP-1 receptor agonists for the treatment of obesity: role as a promising approach. Front Endocrinol (Lausanne). 2023;14:1085799.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6302_CR76","doi-asserted-by":"crossref","unstructured":"Schirra J, Wank U, Arnold R, G\u00f6ke B, Katschinski M. Effects of glucagon-like peptide-1(7\u201336)amide on motility and sensation of the proximal stomach in humans. Gut 2002.","DOI":"10.1136\/gut.50.3.341"},{"key":"6302_CR77","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1513\/AnnalsATS.201510-697OC","volume":"13","author":"T Matsumoto","year":"2016","unstructured":"Matsumoto T, Harada N, Azuma M, Chihara Y, Murase K, Tachikawa R, Minami T, Hamada S, Tanizawa K, Inouchi M, et al. Plasma incretin levels and dipeptidyl Peptidase-4 activity in patients with obstructive sleep apnea. Annals Am Thorac Soc. 2016;13:1378\u201387.","journal-title":"Annals Am Thorac Soc"},{"key":"6302_CR78","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jsr.12552","volume":"26","author":"S Reutrakul","year":"2017","unstructured":"Reutrakul S, Sumritsopak R, Saetung S, Chanprasertyothin S, Anothaisintawee T. The relationship between sleep and glucagon-like peptide 1 in patients with abnormal glucose tolerance. J Sleep Res. 2017;26:756\u201363.","journal-title":"J Sleep Res"},{"key":"6302_CR79","doi-asserted-by":"crossref","unstructured":"Sultana R, Sissoho F, Kaushik VP, Raji MA. The case for early use of Glucagon-like Peptide-1 receptor agonists in obstructive sleep apnea patients with comorbid diabetes and metabolic syndrome. Life (Basel) 2022, 12.","DOI":"10.3390\/life12081222"},{"key":"6302_CR80","unstructured":"Zhou Beini L, Xu, Ke H. Research status of glucagon\u2013like peptide\u20131 receptor agonists on obstructive sleep apnea. Chin J Tuberc Respir Dis 2024:281\u20135."},{"key":"6302_CR81","doi-asserted-by":"crossref","unstructured":"Le KDR, Le K, Foo F. The impact of Glucagon-like peptide 1 receptor agonists on obstructive sleep apnoea: A scoping review. Pharm (Basel) 2024, 12.","DOI":"10.3390\/pharmacy12010011"},{"key":"6302_CR82","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12902-015-0074-6","volume":"15","author":"F Gomez-Peralta","year":"2015","unstructured":"Gomez-Peralta F, Abreu C, Castro JC, Alcarria E, Cruz-Bravo M, Garcia-Llorente MJ, Albornos C, Moreno C, Cepeda M, Almodovar F. An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes. BMC Endocr Disord. 2015;15:78.","journal-title":"BMC Endocr Disord"},{"key":"6302_CR83","doi-asserted-by":"crossref","unstructured":"Grunstein RR, Wadden TA, Chapman JL, Malhotra A, Phillips CL. Giving weight to incretin-based pharmacotherapy for obesity-related sleep apnea: a revolution or a pipe dream? Sleep 2023, 46.","DOI":"10.1093\/sleep\/zsad224"},{"key":"6302_CR84","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1001\/jama.2023.19574","volume":"330","author":"M Sodhi","year":"2023","unstructured":"Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. Risk of Gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. JAMA. 2023;330:1795\u20137.","journal-title":"JAMA"},{"key":"6302_CR85","doi-asserted-by":"crossref","unstructured":"Li S, Vandvik PO, Lytvyn L, Guyatt GH, Palmer SC, Rodriguez-Gutierrez R, Foroutan F, Agoritsas T, Siemieniuk RA, Walsh M. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline. bmj 2021, 373.","DOI":"10.1136\/bmj.n1091"},{"key":"6302_CR86","doi-asserted-by":"crossref","unstructured":"Drager LF. A meta-analysis of Glucagon-like peptide 1 receptor and dual agonists for the treatment of obstructive sleep apnea: end of the history or Ju St the beginning? Sleep 2024:zsaf004.","DOI":"10.1093\/sleep\/zsaf004"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06302-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:19:15Z","timestamp":1743848355000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06302-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6302"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06302-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The named authors have no conflicts of interest, financial or otherwise.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"389"}}